News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
624,953 Results
Type
Article (49382)
Company Profile (194)
Press Release (575377)
Multimedia
Podcasts (76)
Webinars (10)
Section
Business (171400)
Career Advice (3038)
Deals (31325)
Drug Delivery (110)
Drug Development (78378)
Employer Resources (172)
FDA (14955)
Job Trends (14195)
News (302355)
Policy (29987)
Tag
Academia (2780)
Academic (2)
Accelerated approval (4)
Adcomms (27)
Allergies (90)
Alliances (43999)
ALS (94)
Alzheimer's disease (1456)
Antibody-drug conjugate (ADC) (150)
Approvals (14953)
Artificial intelligence (270)
Autoimmune disease (27)
Automation (13)
Bankruptcy (274)
Best Places to Work (11538)
BIOSECURE Act (18)
Biosimilars (106)
Biotechnology (150)
Bladder cancer (80)
Brain cancer (30)
Breast cancer (293)
Cancer (2361)
Cardiovascular disease (188)
Career advice (2556)
Career pathing (34)
CAR-T (169)
Cell therapy (435)
Cervical cancer (21)
Clinical research (63420)
Collaboration (856)
Company closure (1)
Compensation (451)
Complete response letters (24)
COVID-19 (2722)
CRISPR (46)
C-suite (226)
Cystic fibrosis (102)
Data (2202)
Decentralized trials (2)
Denatured (11)
Depression (49)
Diabetes (275)
Diagnostics (6483)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (42)
Drug discovery (130)
Drug pricing (108)
Drug shortages (28)
Duchenne muscular dystrophy (96)
Earnings (70845)
Editorial (44)
Employer branding (22)
Employer resources (151)
Events (97223)
Executive appointments (651)
FDA (16182)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (726)
Gene editing (113)
Generative AI (28)
Gene therapy (328)
GLP-1 (770)
Government (4605)
Grass and pollen (6)
Guidances (61)
Healthcare (18578)
Huntington's disease (22)
IgA nephropathy (31)
Immunology and inflammation (135)
Indications (29)
Infectious disease (2871)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (99)
Interviews (547)
IPO (15704)
IRA (41)
Job creations (3094)
Job search strategy (2109)
Kidney cancer (11)
Labor market (29)
Layoffs (476)
Leadership (24)
Legal (6471)
Liver cancer (79)
Lung cancer (337)
Lymphoma (157)
Machine learning (7)
Management (60)
Manufacturing (291)
MASH (73)
Medical device (12680)
Medtech (12684)
Mergers & acquisitions (16197)
Metabolic disorders (715)
Multiple sclerosis (83)
NASH (23)
Neurodegenerative disease (101)
Neuropsychiatric disorders (27)
Neuroscience (2012)
NextGen: Class of 2025 (6423)
Non-profit (4496)
Now hiring (23)
Obesity (373)
Opinion (267)
Ovarian cancer (78)
Pain (94)
Pancreatic cancer (84)
Parkinson's disease (152)
Partnered (21)
Patents (233)
Patient recruitment (109)
Peanut (50)
People (46671)
Pharmaceutical (42)
Pharmacy benefit managers (17)
Phase I (19839)
Phase II (27918)
Phase III (21150)
Pipeline (1202)
Policy (140)
Postmarket research (2365)
Preclinical (8429)
Press Release (54)
Prostate cancer (111)
Psychedelics (30)
Radiopharmaceuticals (266)
Rare diseases (406)
Real estate (5200)
Recruiting (71)
Regulatory (21045)
Reports (35)
Research institute (2491)
Resumes & cover letters (523)
Rett syndrome (5)
RNA editing (5)
RSV (49)
Schizophrenia (73)
Series A (130)
Series B (81)
Service/supplier (6)
Sickle cell disease (56)
Special edition (16)
Spinal muscular atrophy (159)
Sponsored (32)
Startups (3174)
State (2)
Stomach cancer (15)
Supply chain (60)
Tariffs (36)
The Weekly (63)
Vaccines (735)
Venture capitalists (38)
Weight loss (257)
Women's health (28)
Worklife (20)
Date
Today (135)
Last 7 days (863)
Last 30 days (2566)
Last 365 days (31824)
2025 (10452)
2024 (34610)
2023 (39657)
2022 (50210)
2021 (54644)
2020 (52976)
2019 (46025)
2018 (34839)
2017 (30813)
2016 (29761)
2015 (34054)
2014 (25962)
2013 (21379)
2012 (22672)
2011 (23283)
2010 (20820)
Location
Africa (856)
Alabama (45)
Alaska (6)
Arizona (179)
Arkansas (11)
Asia (37151)
Australia (6383)
California (5844)
Canada (1912)
China (534)
Colorado (257)
Connecticut (269)
Delaware (151)
Europe (84993)
Florida (864)
Georgia (202)
Idaho (53)
Illinois (498)
India (25)
Indiana (278)
Iowa (8)
Japan (155)
Kansas (99)
Kentucky (21)
Louisiana (5)
Maine (62)
Maryland (843)
Massachusetts (4399)
Michigan (200)
Minnesota (359)
Mississippi (2)
Missouri (82)
Montana (22)
Nebraska (22)
Nevada (51)
New Hampshire (58)
New Jersey (1668)
New Mexico (26)
New York (1667)
North Carolina (961)
North Dakota (6)
Northern California (2533)
Ohio (188)
Oklahoma (11)
Oregon (33)
Pennsylvania (1271)
Puerto Rico (10)
Rhode Island (28)
South America (1183)
South Carolina (21)
South Dakota (1)
Southern California (2237)
Tennessee (100)
Texas (847)
United States (21996)
Utah (171)
Virginia (138)
Washington D.C. (55)
Washington State (530)
West Virginia (3)
Wisconsin (53)
624,953 Results for "on target laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
On Target Laboratories Appoints Bill Peters as CEO
December 11, 2024
·
3 min read
Press Releases
Kura Oncology to Participate in Stifel Targeted Oncology Forum
April 1, 2025
·
2 min read
Press Releases
Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum
April 7, 2025
·
2 min read
Press Releases
enGene to Present at the Stifel 2025 Virtual Targeted Oncology Forum
April 1, 2025
·
1 min read
Immunology and Inflammation
I&I Investment Ramps Up With Novel Targets and Boundless Opportunity
Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options in inflammatory bowel disease, atopic dermatitis, myasthenia gravis and more.
February 17, 2025
·
5 min read
·
Kate Goodwin
Press Releases
Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
April 3, 2025
·
1 min read
Press Releases
Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum
April 2, 2025
·
1 min read
Press Releases
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
April 2, 2025
·
1 min read
Press Releases
Innate Pharma to Participate in the 2025 Stifel Virtual Targeted Oncology Forum
April 3, 2025
·
4 min read
Press Releases
Remix Therapeutics to Present at Stifel 2025 Virtual Targeted Oncology Forum
April 1, 2025
·
1 min read
1 of 62,496
Next
